Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Nextech3D.ai Announces First New Customer Win For its AI Powered Photography Studio (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

Healthcare Biotechnology
ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational... see more

Bullboard (NDAQ:PMN)

View:
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
Comment by M101on Jul 23, 2024 2:44pm

RE:RE:Problem for big pharma

The corollary of not holding onto good news is holding back discretionary bad news whenever there is good news anticipated with which it can be coupled.  And in our case the good news is no more ...more  
147
Discussion
Comment by M101on Jul 23, 2024 11:22am

RE:Problem for big pharma

Since when was killing people a problem for big pharma?  And they seem to have no problem limiting PMN's ability to raise cash, however indirectly. A problem for them would be loss of ...more  
106
Discussion
Comment by Hafnesson Jul 23, 2024 11:18am

RE:Problem for big pharma

Agreed. I just feel if they had what they needed  we would have seen it by now. Companies usually don't hold on to good news
88
Discussion
Post by goldtechon Jul 23, 2024 9:23am

Problem for big pharma

Seventy-nine-year-old Genevieve Lane volunteered to take the Alzheimer’s drug Leqembi in a clinical trial because she was forgetting words and misplacing her keys. Infusions of the drug gave her ...more  
160
Discussion
Comment by Gbathaton Jul 19, 2024 5:16pm

RE:RE:Financing Coming

That said, one benefit to partnering with big pharma would be brand recognition and confidence, which might drive the PPS up, especially initially.  At the end of the day, estimation of future ...more  
161
Discussion
Comment by Gbathaton Jul 19, 2024 5:08pm

RE:Financing Coming

Everybody knows this was coming.  You'll pay for it one way or another.  If you partner, you keep more ownership but less future revenue and probably have less control of everything ...more  
114
Discussion
Comment by BottomBrokeron Jul 19, 2024 10:26am

RE:Financing Coming

Devil's advocate: This is good news. It implies that 1A results are positive and they need money to continue with 1B and beyond. 
104
Discussion
Post by goldtechon Jul 18, 2024 9:20pm

Financing Coming

Yes the not so astute Directors screwed the shareholders again. This time we will have a total of 60 million more shares and again cheap warrants to last for years to come. Totally fed up with how ...more  
204
Discussion
Post by Gbathaton Jul 18, 2024 8:51pm

Buying the rumor

and buying the news Long PMN    Haters can hate.  Til the science leads me to believe otherwise, PMN is the diamond in the rough. Closing in on 10,000 shares.  Then it is ...more  
149
Post by goldtechon Jul 17, 2024 5:28pm

Financing

Yes these inept Directors are withholding information so the stock can be priced lower and more dilution. Again and again they screw the shareholders and they get voted in why? One has to ask which ...more  
170
Comment by M101on Jul 17, 2024 1:07pm

RE:RE:RE:RE:Clinical Study data?

The objective is to dangle the carrot, not to feed the donkey. 1a results will be posted when it's time to announce the dilution planned to get through 1b.  
91
Discussion
Post by goldtechon Jul 17, 2024 11:24am

Anne Marie

So how much do we pay her to give us useless news and have her shelter the Directors from their responsibilities. Talk about a useless piece of information. All they do is get paid for nothing.
143
Comment by Hafnesson Jul 17, 2024 11:19am

RE:RE:RE:Clinical Study data?

So they are done with the study, but are going to hold the results. That doesn't make me feel warm and fuzzy. What I understand is that they were gonna give us the results of mid year. This would ...more  
99
Discussion
Comment by Moneyonme123on Jul 17, 2024 9:04am

RE:RE:Clinical Study data?

Thank you for your interest in ProMIS Neurosciences.  The company plans to provide a comprehensive corporate update in its second quarter financial results press release and 10Q filing, which ...more  
127
Discussion
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next